M Cutolo, S Paolino, C Pizzorni - Clin Exp Rheumatol, 2014 - clinexprheumatol.org
Several chronic inflammatory conditions and autoimmune diseases involving different organs and tissues have been found at risk of progression to cancer. A wide array of …
Y Yie, S Zhao, Q Tang, F Zheng, J Wu, LJ Yang… - Molecular and cellular …, 2015 - Springer
Hepatocellular carcinoma (HCC), the major histological subtype of primary liver cancer, remains one of the most common malignancies worldwide. Due to the complicated …
Y Li, J Chen, J Zhang, Z Wang, T Shao, C Jiang, J Xu… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Long non-coding RNAs (lncRNAs) play key roles in diverse biological processes. Moreover, the development and progression of cancer often involves the combined actions of several …
Q Tang, S Zhao, J Wu, F Zheng, LJ Yang, JH Hu… - Cellular signalling, 2015 - Elsevier
Despite the anti-cancer effect of emodin observed in several cancers, the underlying molecular mechanism remains to be elucidated. In this study, we showed that emodin …
Background: The prostate is one of the most common sites for cancer and in contrast prostate tuberculosis seems to be a rare disease. Mycobacterium tuberculosis and cancer …
La etiopatología de la Prostatitis Crónica Síndrome de Dolor Pélvico Crónico (CP/CPPS) no es del todo conocida, sin embargo, se ha observado que tiene un componente autoinmune …
Chronic inflammation is considered to play an important factor in neoplastic progression via the induction of reactive oxygen, reactive nitrogen species and induction of growth …
E Kulchavenya, E Kulchavenya - Current Therapy and Surgery for …, 2016 - Springer
The first anti-tuberculosis drug streptomycin was created in 1945. Before this time the therapy for TB was based on diet and fresh air. Un-controlled using of antibiotics provoked …